Insider · CIK 0001237404
HILL STEPHEN A
Reports to the SEC for 4 companies · WINSTON-SALEM, NC
Transactions
50
Companies
4
Filings
13
CIK
0001237404
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2020-12-16 | LPCNLipocine Inc. · Restricted Stock UnitM Exercise/Conversion | — |
| 2020-12-16 | LPCNLipocine Inc.M Exercise/Conversion | — |
| 2020-06-24 | CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award | — |
| 2020-06-10 | LPCNLipocine Inc. · Stock Options (Right to Buy)A Award | +$21.2K |
| 2020-06-04 | CLRBCellectar Biosciences, Inc.P Purchase | +$19.4K |
| 2019-06-13 | CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award | — |
| 2019-06-12 | LPCNLipocine Inc. · Stock Option (Right to Buy)A Award | +$16.8K |
| 2018-11-29 | CLRBCellectar Biosciences, Inc.S Sale | −$2,075.284 |
| 2018-11-29 | CLRBCellectar Biosciences, Inc.S Sale | −$117.13 |
| 2018-11-29 | CLRBCellectar Biosciences, Inc. · Series A WarrantsS Sale | +$917.403 |
| 2018-11-29 | CLRBCellectar Biosciences, Inc. · WarrantsS Sale | +$27.03 |
| 2018-10-12 | CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award | — |
| 2018-09-06 | GYREGYRE THERAPEUTICS, INC.D Disposition to Issuer | −$1,913.3 |
| 2018-06-27 | LPCNLipocine Inc. · Stock Option (Right to Buy)A Award | +$26.6K |
| 2018-06-13 | GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award | — |
| 2018-02-20 | GYREGYRE THERAPEUTICS, INC. · Redeemable Convertible NoteJ Other | — |
| 2018-02-20 | GYREGYRE THERAPEUTICS, INC. · Redeemable Convertible NoteJ Other | — |
| 2017-12-29 | LPCNLipocine Inc.M Exercise/Conversion | — |
| 2017-12-29 | LPCNLipocine Inc.S Sale | −$4,341.5 |
| 2017-12-29 | LPCNLipocine Inc. · Restricted Stock UnitM Exercise/Conversion | — |
| 2017-07-13 | GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award | — |
| 2017-05-31 | CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award | — |
| 2017-01-26 | LPCNLipocine Inc. · Restricted Stock UnitA Award | — |
| 2016-07-05 | CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award | +$225 |
| 2016-06-14 | LPCNLipocine Inc. · Common Stock (right to buy)A Award | +$80.2K |
| 2016-06-09 | GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award | — |
| 2016-04-20 | CLRBCellectar Biosciences, Inc. · Series A WarrantsP Purchase | +$93.9 |
| 2016-04-20 | CLRBCellectar Biosciences, Inc.P Purchase | +$19.9K |
| 2015-12-17 | GYREGYRE THERAPEUTICS, INC.P Purchase | +$10.1K |
| 2015-10-22 | GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award | — |
| 2015-10-22 | GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award | — |
| 2015-10-22 | GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award | — |
| 2015-08-28 | GYREGYRE THERAPEUTICS, INC.F Tax Payment | −$81.6K |
| 2015-08-14 | GYREGYRE THERAPEUTICS, INC. · Redeemable Convertible NoteA Award | — |
| 2015-06-16 | LPCNLipocine Inc. · Stock Option (Right to Buy)A Award | — |
| 2015-06-09 | CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award | — |
| 2015-02-26 | CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award | — |
| 2014-11-13 | LPCNLipocine Inc.P Purchase | +$19.8K |
| 2014-10-17 | GYREGYRE THERAPEUTICS, INC.A Award | — |
| 2014-08-20 | CLRBCellectar Biosciences, Inc. · Stock purchase warrant (right to buy)P Purchase | +$53 |
| 2014-08-20 | CLRBCellectar Biosciences, Inc.P Purchase | +$19.9K |
| 2014-01-23 | GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award | — |
| 2014-01-06 | LPCNLipocine Inc. · Stock Option (Right to Buy)A Award | — |
| 2013-03-11 | GYREGYRE THERAPEUTICS, INC.P Purchase | +$43.8K |
| 2013-03-11 | GYREGYRE THERAPEUTICS, INC.P Purchase | +$43.8K |
| 2013-03-08 | GYREGYRE THERAPEUTICS, INC.P Purchase | +$44.8K |
| 2013-03-08 | GYREGYRE THERAPEUTICS, INC.P Purchase | +$44.8K |
| 2012-12-03 | GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award | — |
| 2005-01-19 | ARQULE INCEmployee Stock OptionsA Award | — |
| 2004-01-15 | ARQULE INCEmployee Stock OptionsA Award | — |
Recent filings
- 4HILL STEPHEN A0001638599-20-000978SEC(opens sec.gov)
- 4HILL STEPHEN A0001104659-20-076872SEC(opens sec.gov)
- 4HILL STEPHEN A0001638599-20-000593SEC(opens sec.gov)
- 4HILL STEPHEN A0001104659-20-070843SEC(opens sec.gov)
- 4HILL STEPHEN A0001144204-19-031007SEC(opens sec.gov)
- 4HILL STEPHEN A0001638599-19-000610SEC(opens sec.gov)
- 4HILL STEPHEN A0001144204-18-062709SEC(opens sec.gov)
- 4HILL STEPHEN A0001144204-18-053880SEC(opens sec.gov)
- 4HILL STEPHEN A0001209191-18-049987SEC(opens sec.gov)
- 4HILL STEPHEN A0001638599-18-000697SEC(opens sec.gov)
- 4HILL STEPHEN A0001209191-18-038135SEC(opens sec.gov)
- 4HILL STEPHEN A0001209191-18-012438SEC(opens sec.gov)
- 4HILL STEPHEN A0001638599-18-000027SEC(opens sec.gov)
Companies
Address
C/O TARGACEPT, INC. 200 EAST FIRST STREET, SUITE 300
WINSTON-SALEM, NC, 27101